Presentation THT 2022 Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt Presenter: Barry Borlaug February 01, 2022
Presentation THT 2022 REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results Presenter: Sanjiv Shah February 01, 2022
News Industry News Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt November 17, 2020
News Industry News Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial August 27, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017
News Industry News Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure November 14, 2017
News Daily News Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients L.A. McKeown March 29, 2016